Edition:
India

Five Prime Therapeutics Names David Smith CFO


Monday, 5 Nov 2018 

Nov 5 (Reuters) - Five Prime Therapeutics Inc ::FIVE PRIME THERAPEUTICS SAYS DAVID SMITH WILL JOIN CO AS CFO, EFFECTIVE AS OF NOVEMBER 26, 2018 - SEC FILING.FIVE PRIME THERAPEUTICS - EFFECTIVE AS OF NOV 26, 2018, LINDA RUBINSTEIN WILL CEASE TO SERVE AS FIVEPRIME'S INTERIM CFO. 

Company Quote

5.9
-0.48 -7.52%
14 Jun 2019